Stifel cuts Inspire Medical stock target to $190 from $200
Stifel analysts adjusted their outlook on Inspire Medical Systems (NYSE:INSP), reducing the price target to $190 from the previous $200 while maintaining a Hold rating on the stock. The revision ...
Inspire Medical Systems: Hold Rating Amidst Limited Revenue Upside and Slow Inspire V Launch
Stifel Nicolaus analyst Jonathan Block maintained a Hold rating on Inspire Medical Systems (INSP – Research Report) yesterday and set a price ...
Piper Sandler maintains overweight on Inspire Medical stock
Piper Sandler reaffirmed its positive stance on Inspire Medical Systems (NYSE:NYSE:INSP), maintaining an Overweight rating with a $260.00 price target. The endorsement comes after a steep 14.15% ...
Inspire Medical Systems (INSP) Receives a Buy from Lake Street
Lake Street analyst Frank Takkinen reiterated a Buy rating on Inspire Medical Systems (INSP – Research Report) today and set a price target of ...